Edwards cited broader TAVR treatment populations and ongoing evidence generation as key growth drivers for the new year.

WASHINGTON, DC — New European registry data on transcatheter aortic-valve replacement (TAVR) in patients at lower surgical risk than those studied in the pivotal randomized trials offers the ...

Provides interventional cardiologists, cardiothoracic surgeons, and heart teams with practical guidance for selecting patients and performing alternative access transaortic valve replacement (TAVR) ...

IRVINE, Calif.--(BUSINESS WIRE)--JenaValve Technology, Inc., a developer, manufacturer and marketer of next-generation transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic ...